R&D Systems Human IL-17A/F Heterodimer Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Manufacturer: R&D Systems 5194IL025
DescriptionThe Recombinant Human IL-17A/F Heterodimer Protein is derived from E. coli. The Recombinant Human IL-17A/F Heterodimer Protein has been validated for the following applications: Bioactivity.
This product(s) resides on a Fisher Scientific GSA or VA contract. If you are viewing this page as a nonregistered user, the price(s) displayed is List Price. To view your GSA or VA contract pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. You can also view your contract price by searching for this item(s) on GSA Advantage. To place an order, contact Fisher Scientific Customer Service.
|Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein.|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|IL-17A: 15.7 kDa and IL-17F: 15 kDa|
|95%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
|E. coli-derived human IL-17A/F Heterodimer protein, (N-terminus) Met Human IL-17A (Ile20-Ala155) Accession &Num; Q16552 Met Human IL-17F (Arg31-Gln163) Accession &Num; Q96PD4 (C-terminus)|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.